Using a meta-analysis, the association of polymorphisms in IL2RB, IL2RA and IL2 with MS were systemically reviewed, in which significant association for IL2RA and IL2 had been justified (Cavanillas et al., 2010) and the association for IL2RB was deemed to be insignificant. This evidence concerns the gene IL2 and myeloid sarcoma.